Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1016/J.ACTBIO.2021.06.039 | ||||
| Año | 2021 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Adverse local tissue reactions (ALTRs) are a prominent cause of hip implant failure. ALTRs are characterized by aseptic necrosis and leukocyte infiltration of synovial tissue. The prevalence of ALTRs in hips with failing metal implants, with highest rates occurring in patients with metal-on-metal articulations, suggests a role for CoCrMo corrosion in ALTR formation. Although hypersensitivity reactions are the most accepted etiology, the precise cellular mechanism driving ALTR pathogenesis remains enigmatic. Here we show that cobalt ions released by failing hip implants induce mitochondrial stress and cytokine secretion by synovial fibroblasts: the presumptive initiators of ALTR pathogenesis. We found that in-vitro treatment of synovial fibroblasts with cobalt, but not chromium, generated gene expression changes indicative of hypoxia and mitophagy responses also observed in ALTRs biopsies. Inflammatory factors secreted by cobalt-exposed synovial fibroblasts were among those most concentrated in ALTR synovial fluid. Furthermore, both conditioned media from cobalt-exposed synovial fibroblasts, and synovial fluid from ALTRs patients, elicit endothelial activation and monocyte migration. Finally, we identify the IL16/CTACK ratio in synovial fluid as a possible diagnostic marker of ALTRs. Our results provide evidence suggesting that metal ions induce cell stress in synovial fibroblasts that promote an inflammatory response consistent with initiating ALTR formation.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Eltit, Felipe | Hombre |
UNIV BRITISH COLUMBIA - Canadá
Ctr Hip Hlth & Mobil - Canadá The University of British Columbia - Canadá Centre for Hip Health and Mobility - Canadá University of British Columbia, Faculty of Medicine - Canadá |
| 2 | Noble, Jake | Hombre |
UNIV BRITISH COLUMBIA - Canadá
Vancouver Prostate Ctr - Canadá The University of British Columbia - Canadá Vancouver Prostate Centre - Canadá University of British Columbia, Faculty of Medicine - Canadá |
| 3 | Sharma, Manju | Mujer |
UNIV BRITISH COLUMBIA - Canadá
Vancouver Prostate Ctr - Canadá The University of British Columbia - Canadá Vancouver Prostate Centre - Canadá University of British Columbia, Faculty of Medicine - Canadá |
| 4 | Benam, Niloufar | Mujer |
UNIV BRITISH COLUMBIA - Canadá
Vancouver Prostate Ctr - Canadá The University of British Columbia - Canadá Vancouver Prostate Centre - Canadá University of British Columbia, Faculty of Medicine - Canadá |
| 5 | Haegert, Anne | Mujer |
Vancouver Prostate Ctr - Canadá
Vancouver Prostate Centre - Canadá |
| 6 | Bell, Robert H. | Hombre |
Vancouver Prostate Ctr - Canadá
Vancouver Prostate Centre - Canadá |
| 7 | SIMON-PINO, FELIPE ALONSO | Hombre |
Universidad Nacional Andrés Bello - Chile
Instituto Milenio de Oceanografía - Chile Núcleo Milenio de Enfermedades asociadas a Canales Iónicos - Chile Millennium Institute on Immunology and Immunotherapy - Chile |
| 8 | Duncan, Clive | Hombre |
UNIV BRITISH COLUMBIA - Canadá
The University of British Columbia - Canadá |
| 9 | Garbuz, Donald | Hombre |
Ctr Hip Hlth & Mobil - Canadá
UNIV BRITISH COLUMBIA - Canadá Centre for Hip Health and Mobility - Canadá The University of British Columbia - Canadá |
| 10 | Greidanus, Nelson | Hombre |
UNIV BRITISH COLUMBIA - Canadá
The University of British Columbia - Canadá |
| 11 | Masri, Bassam | Hombre |
Ctr Hip Hlth & Mobil - Canadá
UNIV BRITISH COLUMBIA - Canadá Centre for Hip Health and Mobility - Canadá The University of British Columbia - Canadá |
| 12 | Ng, Tony L. | Hombre |
UNIV BRITISH COLUMBIA - Canadá
University of British Columbia, Faculty of Medicine - Canadá The University of British Columbia - Canadá |
| 13 | Wang, Rizhi | - |
UNIV BRITISH COLUMBIA - Canadá
Ctr Hip Hlth & Mobil - Canadá The University of British Columbia - Canadá Centre for Hip Health and Mobility - Canadá University of British Columbia, Faculty of Medicine - Canadá |
| 14 | Cox, Michael | Hombre |
UNIV BRITISH COLUMBIA - Canadá
Vancouver Prostate Ctr - Canadá The University of British Columbia - Canadá Vancouver Prostate Centre - Canadá University of British Columbia, Faculty of Medicine - Canadá |
| Fuente |
|---|
| Comisión Nacional de Investigación Científica y Tecnológica |
| Canadian Institutes of Health Research |
| Natural Sciences and Engineering Research Council of Canada |
| Canadian Institutes of Health Research (CIHR) |
| Chilean Bureau of Science and Technology (CONICYT) |
| ANID-Fondecyt |
| Iniciativa Cientifica Milenio ANID, Chile |
| Collaborative Health Research Projects (CHRP) - Canadian Institutes of Health Research (CIHR) |
| Collaborative Health Research Projects (CHRP) - Natural Sciences and Engineering Research Council of Canada (NCERC) |
| Orthopedic Research Excellence Fund (OREF) - Natural Sciences and Engineering Research Council of Canada (NCERC) |
| Orthopedic Research Excellence Fund |
| Iniciativa Científica Milenio ANID |
| Foshan Science and Technology Bureau |
| Department of Pathology - Vancouver General Hospital |
| Department of Orthopedics of UBC |
| Agradecimiento |
|---|
| This work was supported by grants from the Orthopedic Re-search Excellence Fund (OREF) , and the Collaborative Health Re-search Projects (CHRP) jointly funded by the Natural Sciences and Engineering Research Council of Canada (NCERC) , and the Cana-dian Institutes of Health Research (CIHR) , and ANID-FONDECYT Grant 1201039 . The Millennium Nucleus of Ion Channel-Associated Diseases (MiNICAD) is supported by the Iniciativa Cientifica Mile-nio ANID, Chile. Millennium Institute on Immunology and Im-munotherapy. FE was supported by a scholarship of the Chilean Bureau of Science and Technology (CONICYT) . The authors thank Raman Johal, of the Department of Ortho-pedics of UBC, for the patient recruitment and sample obtaining in this study, Simon Cheung and Margaret Luk, from the Depart-ment of Pathology-Vancouver General Hospital, for their collabo-ration in the sample collection and processing, Dr. David Hart for his contributions to the original planning of this project, and Dr. Anne Hammacher-Brady for her expert mitophagy advice. Author contributions: FE, TN, RW and MC designed the study and experiments. FE conducted the design, sample collection, analysis, experiments and wrote the article. DG, CD, NG and BM con-tributed with the patients' recruitment, sample collection and clin-ical data analysis. JN and MS contributed in the fibroblasts culture, imaging and flow cytometry. FS performed the endothelial cell experiments and helped with manuscript writing. TN provided with histopathological diagnosis and evaluation of biopsies, and immunohistochemistry. RB and AH performed the statistical anal-ysis of the proteomics analysis, and gene expression. The graphical abstract was designed and rendered with support of estudiokbza.cl. |
| This work was supported by grants from the Orthopedic Research Excellence Fund (OREF), and the Collaborative Health Research Projects (CHRP) jointly funded by the Natural Sciences and Engineering Research Council of Canada (NCERC), and the Canadian Institutes of Health Research (CIHR), and ANID-FONDECYT Grant 1201039. The Millennium Nucleus of Ion Channel-Associated Diseases (MiNICAD) is supported by the Iniciativa Científica Milenio ANID, Chile. Millennium Institute on Immunology and Immunotherapy. FE was supported by a scholarship of the Chilean Bureau of Science and Technology (CONICYT). The authors thank Raman Johal, of the Department of Orthopedics of UBC, for the patient recruitment and sample obtaining in this study, Simon Cheung and Margaret Luk, from the Department of Pathology - Vancouver General Hospital, for their collaboration in the sample collection and processing, Dr. David Hart for his contributions to the original planning of this project, and Dr. Anne Hammacher-Brady for her expert mitophagy advice. Author contributions: FE, TN, RW and MC designed the study and experiments. FE conducted the design, sample collection, analysis, experiments and wrote the article. DG, CD, NG and BM contributed with the patients’ recruitment, sample collection and clinical data analysis. JN and MS contributed in the fibroblasts culture, imaging and flow cytometry. FS performed the endothelial cell experiments and helped with manuscript writing. TN provided with histopathological diagnosis and evaluation of biopsies, and immunohistochemistry. RB and AH performed the statistical analysis of the proteomics analysis, and gene expression. The graphical abstract was designed and rendered with support of estudiokbza.cl. |
| This work was supported by grants from the Orthopedic Research Excellence Fund (OREF), and the Collaborative Health Research Projects (CHRP) jointly funded by the Natural Sciences and Engineering Research Council of Canada (NCERC), and the Canadian Institutes of Health Research (CIHR) , and ANID-FONDECYT Grant 1201039 . The Millennium Nucleus of Ion Channel-Associated Diseases (MiNICAD) is supported by the Iniciativa Científica Milenio ANID, Chile. Millennium Institute on Immunology and Immunotherapy. FE was supported by a scholarship of the Chilean Bureau of Science and Technology (CONICYT). |